Lumentum Analyst Starts Coverage Optimistically; Check Out Tuesday's Top 5 Initiations
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 18 2025
0mins
Source: Benzinga
Analyst Coverage Initiations: Several Wall Street analysts have initiated coverage on various companies, providing new ratings and price targets for investors to consider.
Kestra Medical Technologies: BTIG analyst Marie Thibault rated Kestra Medical Technologies Ltd (KMTS) as a Buy with a price target of $32, while the stock closed at $25.10.
Innospec Inc: Freedom Capital Markets analyst David Silver also rated Innospec Inc (IOSP) as a Buy, setting a price target of $93, with shares closing at $72.23.
Other Notable Ratings: UBS's Michael Goldsmith rated Sabra Health Care REIT Inc (SBRA) as Neutral with a $20 target, while Mizuho's Vijay Rakesh rated Lumentum Holdings Inc (LITE) as Outperform with a $290 target.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SBRA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SBRA
Wall Street analysts forecast SBRA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SBRA is 20.83 USD with a low forecast of 20.00 USD and a high forecast of 22.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Analyst Rating
3 Buy
4 Hold
0 Sell
Moderate Buy
Current: 18.520
Low
20.00
Averages
20.83
High
22.00
Current: 18.520
Low
20.00
Averages
20.83
High
22.00
About SBRA
Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada. Its primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector. Its investment portfolio primarily comprises skilled nursing/transitional care facilities, senior housing communities (Senior Housing - Leased), behavioral health facilities, and specialty hospitals and other facilities, in each case leased to third-party operators; senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed); investments in joint ventures; loans receivable, and preferred equity investments. Its real estate properties held for investment included 37,047 beds/units, spread across the United States and Canada.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Sabra Health Care REIT Announces 2025 Distribution Tax Treatment
- Distribution Overview: Sabra Health Care REIT announces a cash distribution of $0.30 per share for 2025, covering multiple distributions for common stock, indicating the company's stable cash flow and commitment to shareholder returns.
- Tax Treatment Details: The 2025 non-qualified ordinary dividends will be reported on Form 1099-DIV, Box 5, requiring shareholders to hold REIT shares for at least 45 days to comply with Section 199A tax requirements, ensuring compliance and tax optimization.
- Distribution Composition: The total distribution for 2025 amounts to $1.20, with 81.29% classified as ordinary dividends and 18.71% as non-dividend distributions, reflecting the company's transparency in distribution structure and accountability to investors.
- Company Background: Sabra Health Care REIT operates as a self-administered, self-managed real estate investment trust focused on healthcare real estate investments across the U.S. and Canada, showcasing its expertise and market position in the healthcare sector.
Continue Reading
KBW Announces Q4 2025 Index Rebalancing with Changes Across Six Indices
- Index Component Changes: The KBW Nasdaq Insurance Index adds four companies, including Arthur J. Gallagher & Co. and Chubb Limited, while dropping four others, reflecting market dynamics.
- Regional Banking Index Update: The KBW Nasdaq Regional Banking Index adds Axos Financial, Inc. and removes Synovus Financial Corp., indicating a focus on emerging fintech companies.
- Dividend Yield Index Adjustments: The KBW Nasdaq Financial Sector Dividend Yield Index adds eight companies and drops eight, demonstrating ongoing investor interest in high-yield investments.
- REIT Index Expansion: The KBW Nasdaq Premium Yield Equity REIT Index adds twelve companies while removing nine, reflecting the vibrancy of the real estate market and investor confidence.
Continue Reading